Clinical Trial Update: Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 clinical trial evaluating a short course combination of miltefosine and liposomal amphotericin B for visceral …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Visceral Leishmaniasis

Drugs mentioned

• AMBISOME (AMPHOTERICIN B)
• Miltefosine (miltefosine)

Snippet

Sponsor: Banaras Hindu University | Conditions: Visceral Leishmaniasis | Phase 2 | Status: COMPLETED